Literature DB >> 20579958

The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke.

Elizabeth C Miller1, Huiling Cao, Shi Wu Wen, Qiuying Yang, Julie Lafleche, Mark Walker.   

Abstract

OBJECTIVE: Maternal smoking and preeclampsia independently increase the risk of adverse pregnancy outcomes; however, smoking decreases the risk of preeclampsia. We sought to estimate the risk of adverse pregnancy outcomes among preeclamptic women who smoke and hypothesized that this risk would be increased, compared with nonpreeclamptic women who smoke or preeclamptic women who do not smoke. STUDY
DESIGN: With the use of the Niday Perinatal Database and multiple logistic regressions, we estimated the risk of adverse pregnancy outcomes in nonpreeclamptic women who smoke, preeclamptic women who do not smoke, and preeclamptic women who smoke in relation to nonpreeclamptic women who do not smoke.
RESULTS: The incidence of adverse pregnancy outcomes was more than twice as high among preeclamptic women who smoke as among nonpreeclamptic women who do not smoke. The following data were observed: small-for-gestational-age infant (odds ratio [OR], 3.40; 95% CI, 2.27-4.89), preterm birth (OR, 5.77; 95% CI, 4.50-7.35), very preterm birth (OR, 5.44; 95% CI, 3.51-8.11), abruption (OR, 6.16; 95% CI, 3.05-11.01), Apgar <4 at 5 minutes (OR, 3.11; 95% CI, 1.48-5.72), and stillbirth (OR, 3.39; 95% CI, 1.33-6.99).
CONCLUSION: Smoking decreases the risk of preeclampsia, but smokers with preeclampsia have an increased risk for adverse pregnancy outcomes.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20579958     DOI: 10.1016/j.ajog.2010.05.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Neighborhood safety as a correlate of tobacco use in a sample of urban, pregnant women.

Authors:  Freda Patterson; Laura Seravalli; Alexandra Hanlon; Deborah B Nelson
Journal:  Addict Behav       Date:  2012-05-26       Impact factor: 3.913

Review 3.  Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure.

Authors:  Melissa Suter; Adi Abramovici; Kjersti Aagaard-Tillery
Journal:  Pediatr Endocrinol Rev       Date:  2010-12

Review 4.  Select Prenatal Environmental Exposures and Subsequent Alterations of Gene-Specific and Repetitive Element DNA Methylation in Fetal Tissues.

Authors:  Benjamin B Green; Carmen J Marsit
Journal:  Curr Environ Health Rep       Date:  2015-06

5.  Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis.

Authors:  A Abramovici; R E Gandley; R G Clifton; K J Leveno; L Myatt; R J Wapner; J M Thorp; B M Mercer; A M Peaceman; P Samuels; A Sciscione; M Harper; G Saade; Y Sorokin
Journal:  BJOG       Date:  2014-12-17       Impact factor: 7.331

Review 6.  Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths.

Authors:  Mehnaz Jabeen; Mohammad Yawar Yakoob; Aamer Imdad; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

7.  Left truncation bias as a potential explanation for the protective effect of smoking on preeclampsia.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

8.  Smoking among older childbearing women - a marker of risky health behaviour a registry-based study in Finland.

Authors:  Reeta Lamminpää; Katri Vehviläinen-Julkunen; Mika Gissler; Seppo Heinonen
Journal:  BMC Public Health       Date:  2013-12-13       Impact factor: 3.295

Review 9.  Maternal smoking and the risk of still birth: systematic review and meta-analysis.

Authors:  Takawira C Marufu; Anand Ahankari; Tim Coleman; Sarah Lewis
Journal:  BMC Public Health       Date:  2015-03-13       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.